Microneurography and venous occlusion plethysmography in heart failure: Correlation with prognosis;Microneurografia e pletismografia de oclusão venosa na insuficiência cardíaca: Correlação com prognóstico

Arquivos Brasileiros de Cardiologia

Volumn 92, Issue 1, 2009, Pages 44-51

  Munhoz, Robinson Tadeu ^a,b   Negrão, Carlos Eduardo ^a   Barretto, Antonio Carlos Pereira ^a   Ochiai, Marcelo Eidi ^a   Cardoso, Juliano Novaes ^a   Morgado, Paulo Cesar ^a   Del Carlo, Carlos Henrique ^a   Ramires, José Antonio Franchini ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Electromiography; Heart failure; Plethysmography; Prognosis

Indexed keywords

CAPTOPRIL; CARVEDILOL; DIGOXIN; DOBUTAMINE; FUROSEMIDE; HYDRALAZINE; ISOSORBIDE DINITRATE; SPIRONOLACTONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DEATH; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FOLLOW UP; FOREARM; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MICRONEUROGRAPHY; MUSCLE BLOOD FLOW; NEUROGRAPHY; PERONEUS NERVE; PROGNOSIS; SURVIVAL; SYMPATHETIC TONE; VEIN OCCLUSION PLETHYSMOGRAPHY;

EID: 60949110399     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2009000100008     Document Type: Article

References (25)

1. Mancia G. Sympathetic activation in congestive heart failure. Eur Heart J.1990;11(Suppl A):3-11..
2. Packer M. New concepts in the pathophysiology of heart failure: beneficial and deleterious interaction of endogenous haemodynamic and neurohormonal mechanisms. J Intern Med.1996;239(4):327-33..
3. Cohn JN, Levine B, Olivari MT, Garberg V, Lura D, Francis GS.;et al. Plasma norepinefrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med.1984;311(13):819-23.
4. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev. 1990; 70(4):963-85
5. Braunwald E.(ed.)Heart disease. Philadelphia:WB Saunders;1962.p.447-66.
6. Wallin BG. Intraneural recording and autonomic function in man. In Bannister R ( ed ), Autonomic failure. Oxford: Oxford University Press;1983.p.36-51.
7. Delius W, Hagbarth KE, Hongel A, Wallin B.G. General characteristics of sympatethic activity in human muscle nerves.Acta Physiol Scand. 1972;84(1):65-81.
8. Ferguson DW, Berg WJ, Sanders JS. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart filure: evidence from direct microneurographic recordings. J Am Coll Cardiol, 1990;16(5):1125-34..
9. Leimbach WN, Wallin BG, Victor RG., Ayward P.E, Sundlof G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in pacients with heart failure. Circulation.1986;73(5):913-9..
10. Negrão CE, Rondon MU, Tinucci T, Alves MJN, Roveda F, Braga, A.M.W et al. Abnormal neurovascular control during exercise is linked to heart failure severity. Am J Physiol Heart Circ Physiol.2001;280(3):H1286-92
11. Nakamura, M. Peripheral vascular remodeling in chronic heart failure: Clinical relevance and new conceptualization of its mechanisms. J Card Fail.1999;5(2):127-38.
12. Mombouli JV, Vanhoutte PM. Endothelial dysfunction: from physiology to Therapy. J Mol Cell Cardiol. .1999;31(1):61-74..
13. Gryglewsky RJ, Botting RM, Vane JR. Mediators produced by the endotelial cell. Hypertension.1988;12(6):530-48.
14. Drexler, H. Endothelium function in heart failure : some unsolved issues. Eur Heart J.1996;17(12):1775-7.
15. Joannides R, Haefeli W.E, Linder L, Richard V, Luscher, T.F. Nitric oxide is responsible for flow -dependent dilatation of human peripheral conduit arteries in vivo. Circulation.1995;91(5):1314-9.
16. Winlaw DS, Smythe G.A, Keogh A.M, Schyvens CG. Increased nitric oxide production in heart failure. Lancet.1994;344(8919):373-4.
17. Katz SD, Biasucci L, Sabba C, Strom JÁ, Solomon S, Nikolic SD.et al. Impaired endothelium mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol .1992;19(5):918-25.
18. Habib F., Dutka D, Crossman D, Oakley CM,Cleland JG.Enhanced basal nitric oxide production in heart failure :another failed counter regulatory vasodilator mechanism? Lancet.1994;344(8919):371-3.
19. Yoshida H., Nakamura M, Akatsu T, Arakawa , Hiramori K. Effects of nitric oxide inhibition on basal forearm bood flow in patients with non-ischemic chronic heart failure. Heart Vessels.1998;13(3):142-6.
20. Kubo SH, Rector TS, Bank AJ, Willians RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation.1991;84(4):1589-96..
21. Negrão C.E, Gregg C, Jaime D, Middlekauff H.R. Impaired endothelium-mediated vasodilation is not the principal cause of vasoconstriction in heart failure. Am J Physiol Heart Circ PHysiol.2000;278(1):H168-74..
22. Nakamura M, Arakawa N, Yoshida H, Saitoh S, Hiramori K. Blunted peripheral vasodilatory response is a hallmark of progressive deterioration in mild to moderate congestive heart failure. J Card Fail.2001;7(1):38-44..
23. SOLVD Investigators, Effect of enalapril on survival in pacients whith reduced left ventricular ejection fractions and congestive heart failure. N. Engl.J.Med.1991;325(5):293-302..
24. SOLVD Investigators, Effect of enalapril on mortality and the development of heart failure in asyntomatic patients with reduced left ventricular ejection fraction.N Engl J Med.1992;327(10):685-91.
25. Cohn JN. The management of chronic heart failure. N Engl J Med.1996;335(7):490-8.